Home/Filings/4/0001213900-22-074723
4//SEC Filing

Townsend John 4

Accession 0001213900-22-074723

CIK 0001766140other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 8:00 AM ET

Size

5.2 KB

Accession

0001213900-22-074723

Insider Transaction Report

Form 4
Period: 2022-11-21
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2022-11-21+35,00076,861 total
    Exercise: $0.75Exp: 2032-11-21Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]8,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001511906

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 8:00 AM ET
Size
5.2 KB